Wednesday, January 22, 2020 4:14:44 PM
Exhibit 99.1
TO: Todd S. Caven
Chief Financial Officer and
Director / Board Member
Regen BioPharma, Inc.
Zander Therapeutics, Inc.
KCL Therapeutics, Inc.
RE: Resignation as officer and director of Regen BioPharma Inc., Zander Therapeutics Inc. and KCL Therapeutics Inc.
Effective as of 1 pm Pacific Standard Time on January 22, 2020 I resign my positions as Chairman of the Board of Directors, Chief Executive Officer and any and all other offices I may hold of Regen BioPharma Inc., Zander Therapeutics Inc. and KCL Therapeutics Inc.
This leaves you serving as the sole officer and director of the abovementioned three corporations.
I am available to serve as a consultant should you desire. Terms of such service shall be negotiated separately on a case by case basis.
Sincerely,
/s/ David R. Koos
David R. Koos
1/22/2020
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM